Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients
Sponsor: Centre Jean Perrin
Summary
The INSTIGO study aims to assess a plasma protein profile at different stages of patient follow-up as a predictive factor of metastatic recurrence in triple negative breast cancer. It also aims to look at other potential biomarkers of metastatic relapse such as Tumor-infiltrating Lymphocytes, circulating tumor DNA, figurative elements in blood, or a tumor RNA signature.
Official title: INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
90
Start Date
2020-11-27
Completion Date
2029-11-09
Last Updated
2025-12-04
Healthy Volunteers
No
Conditions
Locations (1)
Centre Jean PERRIN
Clermont-Ferrand, France